Canada markets close in 45 minutes

Adamas Pharmaceuticals, Inc. (ADMS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
7.99+0.02 (+0.25%)
As of 3:13PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close7.97
Open8.00
Bid7.99 x 4000
Ask8.00 x 4000
Day's Range7.98 - 8.00
52 Week Range2.96 - 9.15
Volume831,153
Avg. Volume960,952
Market Cap365.067M
Beta (5Y Monthly)2.60
PE Ratio (TTM)N/A
EPS (TTM)-1.60
Earnings DateNov. 03, 2021 - Nov. 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.60
  • Motley Fool

    Why Supernus' Acquisition of Adamas Is a Smart Move

    Supernus Pharmaceuticals (NASDAQ: SUPN) recently announced that it's acquiring Adamas Pharmaceuticals (NASDAQ: ADMS). In this Motley Fool Live video recorded on Oct. 13, Motley Fool contributors Keith Speights and Brian Orelli discuss why Supernus' planned acquisition of Adamas is a smart move.

  • GlobeNewswire

    Lifshitz Law Firm, P.C. Announces Investigation of ADMS, ACBI, FLXN, and HBMD

    NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (NasdaqGM: ADMS) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of ADMS to Supernus Pharmaceuticals, Inc. for $8.10 in cash per share of ADMS owned. If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at

  • ACCESSWIRE

    MERGER ALERT - ADMS, AZPN, and FLXN: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

    NEW YORK, NY / ACCESSWIRE / October 19, 2021 / The following statement is being issued by Levi & Korsinsky, LLP:Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. (NASDAQ:ADMS)Agreement Announcement: October 11, 2021 Transaction Details:Upon the closing of the transaction, Supernus will acquire Adamas through a tender offer for $8.